Article(id=1325223678186762995, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223620166943241, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2026.05.007, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1756051200000, receivedDateStr=2025-08-25, revisedDate=1775923200000, revisedDateStr=2026-04-12, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887546345, onlineDateStr=2026-11-05, pubDate=1778342400000, pubDateStr=2026-05-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887546345, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887546345, creator=13701087609, updateTime=1793887546345, updator=13701087609, issue=Issue{id=1325223620166943241, tenantId=1146029695717560320, journalId=1319690329412173987, year='2026', volume='47', issue='5', pageStart='455', pageEnd='588', issueExtLink='null', onlineDate='null', pubDate='1778342400000', pubDateStr='2026-05-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887532512, creator='13701087609', updateTime=1793934786637, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325421818395361842, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223620166943241, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325421818395361843, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325223620166943241, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=502, endPage=507, ext={EN=ArticleExt(id=1325223678400672500, articleId=1325223678186762995, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Exploration of the therapeutic mechanism of mepolizumab in patients with type 2 inflammatory bronchial asthma, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective

To evaluate the therapeutic mechanism of mepolizumab in type 2 inflammatory bronchial asthma.

Methods

The clinical data of 102 patients with type 2 bronchial asthma who were treated in our hospital from March 2024 to January 2025 were collected retrospectively. They were grouped according to different treatment regimens. The control group treated with budesonide formoterol and oral glucocorticosteroid(OCS) prednisone, while the observation group received mepolizumab in addition to the control group. The conditions of both groups after 6 months of treatment were collected and compared, including asthma control test(ACT) score, OCS dosage, eosinophil(EOS) count,immunoglobulin(Ig)E, fractional exhaled nitric oxide(FeNO), forced vital capacity(FVC), forced expiratory volume in one second(FEV1), peak expiratory flow(PEF), total bronchial surface area(TA), lumen area(LA), and wall area of tube(WA), and the number of readmissions due to asthma exacerbation over a 12-month follow-up period.

Results

After treatment, the ACT score and OCS dosage in the observation group decreased more significantly compared with the control group(P<0.05), while the EOS count, IgE, and FeNO were lower in the observation group than in the control group(P<0.05), and the FVC, FEV1/FVC, and PEF in the observation group were higher than those in the control group(P<0.05).The LA in the observation group was higher than that in the control group(P<0.05), and the WA was lower than that in the control group(P<0.05), the 12-month follow-up showed that the number of re-admissions due to asthma exacerbation in the observation group was less than those in the control group(P<0.05). The multivariate logistic regression analysis showed that baseline EOS and FeNO were independent predictors for evaluating treatment response based on the ACT scoring(P<0.05).

Conclusion

Mepolizumab helps control the condition of type 2 inflammatory bronchial asthma, reduces the dosage of OCS. The main mechanism of action is speculated to be targeting the blockade of type 2 inflammatory biomarkers and improving airway remodeling.

, authors=Xiaoqin SHENa, Yongwei LIb, Debing ZHOUb, *, authorsList=Xiaoqin SHEN, Yongwei LI, Debing ZHOU, authorCompany=null, correspAuthors=Debing ZHOU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325223678702662389, articleId=1325223678186762995, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=美泊利珠单抗对2型炎症支气管哮喘患者的治疗机制探索, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的

评价美泊利珠单抗对2型炎症支气管哮喘的治疗机制。

方法

回顾性收集我院2024年3月至2025年1月接受治疗的102例2型支气管哮喘患者的临床资料,依照不同治疗方案分组。对照组治疗方案包括布地奈德福莫特罗、口服糖皮质激素(oral glucocorticosteroid,OCS)泼尼松;观察组在对照组治疗基础上联用美泊利珠单抗。收集并比较两组治疗6个月的情况,包括哮喘控制测试(asthma control test,ACT)评分、OCS用量、嗜酸性粒细胞(eosinophil,EOS)计数、免疫球蛋白(immunoglobulin,Ig)E、呼出气一氧化氮(fractional exhaled nitric oxide,FeNO)、用力肺活量(forced vital capacity,FVC)、第1秒用力呼气容积(forced expiratory volume in one second,FEV1)、呼气峰值流量(peak expiratory flow,PEF)、支气管总面积(total bronchial surface area,TA)、管腔面积(lumen area,LA)、管壁面积(wall area of tube,WA)等指标结果,并比较随访12个月的因哮喘加重再入院的次数。

结果

治疗后,观察组ACT评分、OCS用量较对照组的降低更明显(P<0.05),EOS计数、IgE、FeNO水平较对照组更低(P<0.05),且观察组FVC、FEV1/FVC、PEF较对照组更高(P<0.05)。观察组LA高于对照组(P<0.05),WA低于对照组(P<0.05)。随访12个月,结果显示,观察组因哮喘加重的再入院次数少于对照组(P<0.05);经多因素逻辑回归分析显示,基线EOS、FeNO是基于ACT评分评价治疗应答的独立预测因素(P<0.05)。

结论

美泊利珠单抗有助控制2型炎症支气管哮喘病情,帮助减少OCS用量,推测主要作用机制与靶向阻断2型炎症生物标志物、改善气道重构有关。

, authors=沈小钦a, 李永伟b, 周德兵b, *, authorsList=沈小钦, 李永伟, 周德兵, authorCompany=null, correspAuthors=周德兵, authorNote=

沈小钦,副主任医师,研究方向:慢性气道疾病与肺部感染性疾病。

, correspAuthorsNote=
周德兵,副主任药师,研究方向:抗感染领域。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=mWvcu3SaDbRws3JKqMPSpg==, magXml=GaBidKZniOR0fYLEVh9JVQ==, pdfUrl=null, pdf=DqL5u/vqUcT82yrSI+6TfQ==, pdfFileSize=1056006, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=F5Z82DCEpyv1Rl4XUdL45A==, mapNumber=null, fund=null)}, authors=[Author(id=1325223679478608637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223679566689023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, authorId=1325223679478608637, language=EN, stringName=Xiaoqin SHEN, firstName=Xiaoqin, middleName=null, lastName=SHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=a, address=a.Department of Respiratory and Critical Care Medicine, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223679902233345, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, authorId=1325223679478608637, language=CN, stringName=沈小钦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=a, address=a.安岳县人民医院呼吸与危重症科,四川 资阳 642350, bio={"content":"

沈小钦,副主任医师,研究方向:慢性气道疾病与肺部感染性疾病。

"}, bioImg=null, bioContent=

沈小钦,副主任医师,研究方向:慢性气道疾病与肺部感染性疾病。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223678908183286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, xref=a., ext=[AuthorCompanyExt(id=1325223678920766199, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223678908183286, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.Department of Respiratory and Critical Care Medicine, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China), AuthorCompanyExt(id=1325223678924960504, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223678908183286, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.安岳县人民医院呼吸与危重症科,四川 资阳 642350)])]), Author(id=1325223681550594819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223681655452421, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, authorId=1325223681550594819, language=EN, stringName=Yongwei LI, firstName=Yongwei, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=b, address=b.Department of Clinical Pharmacy, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223681739338502, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, authorId=1325223681550594819, language=CN, stringName=李永伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=b, address=b.安岳县人民医院临床药学科,四川 资阳 642350, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223679105315577, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, xref=b., ext=[AuthorCompanyExt(id=1325223679126287098, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223679105315577, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.Department of Clinical Pharmacy, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China), AuthorCompanyExt(id=1325223679134675707, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223679105315577, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.安岳县人民医院临床药学科,四川 资阳 642350)])]), Author(id=1325223681844196104, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223681949053706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, authorId=1325223681844196104, language=EN, stringName=Debing ZHOU, firstName=Debing, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=b, *, address=b.Department of Clinical Pharmacy, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223682041328395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, authorId=1325223681844196104, language=CN, stringName=周德兵, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=b, *, address=b.安岳县人民医院临床药学科,四川 资阳 642350, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223679105315577, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, xref=b., ext=[AuthorCompanyExt(id=1325223679126287098, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223679105315577, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.Department of Clinical Pharmacy, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China), AuthorCompanyExt(id=1325223679134675707, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223679105315577, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.安岳县人民医院临床药学科,四川 资阳 642350)])])], keywords=[Keyword(id=1325223682150380300, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, language=EN, orderNo=1, keyword=type 2 inflammatory bronchial asthma), Keyword(id=1325223682217489165, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, language=EN, orderNo=2, keyword=mepolizumab), Keyword(id=1325223682292986638, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, language=EN, orderNo=3, keyword=glucocorticosteroid), Keyword(id=1325223682402038543, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, language=EN, orderNo=4, keyword=pulmonary function), Keyword(id=1325223682519479056, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, language=EN, orderNo=5, keyword=airway remodeling), Keyword(id=1325223682624336657, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, language=CN, orderNo=1, keyword=2型炎症支气管哮喘), Keyword(id=1325223682712417042, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, language=CN, orderNo=2, keyword=美泊利珠单抗), Keyword(id=1325223682804691731, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, language=CN, orderNo=3, keyword=糖皮质激素), Keyword(id=1325223682896966420, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, language=CN, orderNo=4, keyword=肺功能), Keyword(id=1325223682980852501, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, language=CN, orderNo=5, keyword=气道重塑)], refs=[Reference(id=1325223683106681622, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=MATUCCI A, MICHELETTO C, VULTAGGIO A. Severe asthma and biologics: managing complex patients[J]. J Investig Allergol Clin Immunol, 2023, 33(3): 168-178., articleTitle=null, refAbstract=null), Reference(id=1325223683198956311, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=DENG Z, JIN M, OU C, et al. Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies[J]. Chin Med J(Engl), 2023, 136(2): 230-232., articleTitle=null, refAbstract=null), Reference(id=1325223683303813912, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会呼吸病学分会. 支气管哮喘防治指南(2024 年版)[J]. 中华结核和呼吸杂志, 2025, 48(3): 208-248., articleTitle=null, refAbstract=null), Reference(id=1325223683404477209, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=THOMAS D, MCDONALD VM, STEVENS S, et al.Biologics(mepolizumab and omalizumab) induced remission in severe asthma patients[J]. Allergy, 2024, 79(2): 384-392., articleTitle=null, refAbstract=null), Reference(id=1325223683479974682, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=王雯, 郭越, 李洁莹, 等. 度普利尤单抗治疗中重度哮喘的疗效及安全性分析: 一项真实世界研究[J]. 中国呼吸与危重监护杂志, 2023, 22(10): 685-691., articleTitle=null, refAbstract=null), Reference(id=1325223683547083547, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=乌日娜, 杨敬平, 徐喜媛. 肺功能及哮喘控制测试(ACT)在哮喘患者管理中的价值[J]. 临床肺科杂志, 2012, 17(7):1232-1233., articleTitle=null, refAbstract=null), Reference(id=1325223683639358236, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=张明强, 牟向东. 2 型炎症型支气管哮喘的生物靶向治疗[J]. 新医学, 2024, 55(11): 944-949., articleTitle=null, refAbstract=null), Reference(id=1325223683735827229, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=LOMMATZSCH M, BRUSSELLE GG, LEVY ML, et al. A2BCD:a concise guide for asthma management[J]. Lancet Respir Med, 2023, 11(6): 573-576., articleTitle=null, refAbstract=null), Reference(id=1325223683815519006, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=AKENROYE AT, SEGAL JB, ZHOU G, et al. Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: a target trial emulation[J]. J Allergy Clin Immunol,2023, 151(5): 1269-1276., articleTitle=null, refAbstract=null), Reference(id=1325223683907793695, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=NOPSOPON T, LASSITER G, CHEN ML, et al. Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: a Bayesian network meta-analysis[J]. J Allergy Clin Immunol, 2023, 151(3): 747-755., articleTitle=null, refAbstract=null), Reference(id=1325223684021039904, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=LIU MC, BAGNASCO D, MATUCCI A, et al. Mepolizumab in patients with severe asthma and comorbidities: 1-year REALITI-A analysis[J]. J Allergy Clin Immunol Pract, 2023,11(12): 3650-3661., articleTitle=null, refAbstract=null), Reference(id=1325223684151063329, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=DIGHRIRI IM, ALNUGHAYTHIR AI, ALBESISI AA, et al.Efficacy and safety of mepolizumab in the management of severe eosinophilic asthma: a systematic review[J]. Cureus,2023, 15(12): e49781., articleTitle=null, refAbstract=null), Reference(id=1325223684239143714, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=李亚, 杨卫, 张红, 等. 血清炎症因子与支气管哮喘气道重构相关性的研究进展[J]. 医学综述, 2023, 29(8): 1492-1496., articleTitle=null, refAbstract=null), Reference(id=1325223684327224099, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=SAVIN IA, ZENKOVA MA, SEN KOVA AV. Bronchial asthma, airway remodeling and lung fibrosis as successive steps of one process[J]. Int J Mol Sci, 2023, 24(22): 16042., articleTitle=null, refAbstract=null), Reference(id=1325223686034305828, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=徐震, 张海生, 赵杰, 等. 美泊利单抗治疗严重哮喘患者的临床研究[J]. 中国临床药理学杂志, 2025, 41(13): 1811-1815., articleTitle=null, refAbstract=null), Reference(id=1325223686143357733, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=STRAUSS R, LEFLEIN H, KOLESAR A, et al. Long-term efficacy and safety among patients with severe eosinophilic asthma treated with mepolizumab and its effect on small airways[J]. J Allergy Clin Immunol Pract, 2023, 11(12):3670-3679., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1325223678908183286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, xref=a., ext=[AuthorCompanyExt(id=1325223678920766199, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223678908183286, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.Department of Respiratory and Critical Care Medicine, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China), AuthorCompanyExt(id=1325223678924960504, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223678908183286, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.安岳县人民医院呼吸与危重症科,四川 资阳 642350)]), AuthorCompany(id=1325223679105315577, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, xref=b., ext=[AuthorCompanyExt(id=1325223679126287098, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223679105315577, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.Department of Clinical Pharmacy, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China), AuthorCompanyExt(id=1325223679134675707, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223679105315577, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.安岳县人民医院临床药学科,四川 资阳 642350)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.05.007, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.05.007, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2026.05.007, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2026.05.007, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1778342400000, fullTextJson=null, articleText=null, reference=null)
收藏切换
美泊利珠单抗对2型炎症支气管哮喘患者的治疗机制探索
沈小钦 a , 李永伟 b , 周德兵 b, *
世界临床药物 | 研究论文 2026,47(5): 502-507
收起
收藏切换
世界临床药物 |研究论文 2026 , 47 (5) : 502 -507
美泊利珠单抗对2型炎症支气管哮喘患者的治疗机制探索
全屏
[Author(id=1325223679478608637, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223679566689023, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, authorId=1325223679478608637, language=EN, stringName=Xiaoqin SHEN, firstName=Xiaoqin, middleName=null, lastName=SHEN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=a, address=a.Department of Respiratory and Critical Care Medicine, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223679902233345, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, authorId=1325223679478608637, language=CN, stringName=沈小钦, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=a, address=a.安岳县人民医院呼吸与危重症科,四川 资阳 642350, bio={"content":"

沈小钦,副主任医师,研究方向:慢性气道疾病与肺部感染性疾病。

"}, bioImg=null, bioContent=

沈小钦,副主任医师,研究方向:慢性气道疾病与肺部感染性疾病。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223678908183286, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, xref=a., ext=[AuthorCompanyExt(id=1325223678920766199, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223678908183286, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.Department of Respiratory and Critical Care Medicine, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China), AuthorCompanyExt(id=1325223678924960504, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223678908183286, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=a.安岳县人民医院呼吸与危重症科,四川 资阳 642350)])]), Author(id=1325223681550594819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325223681655452421, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, authorId=1325223681550594819, language=EN, stringName=Yongwei LI, firstName=Yongwei, middleName=null, lastName=LI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=b, address=b.Department of Clinical Pharmacy, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223681739338502, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, authorId=1325223681550594819, language=CN, stringName=李永伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=b, address=b.安岳县人民医院临床药学科,四川 资阳 642350, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223679105315577, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, xref=b., ext=[AuthorCompanyExt(id=1325223679126287098, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223679105315577, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.Department of Clinical Pharmacy, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China), AuthorCompanyExt(id=1325223679134675707, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223679105315577, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.安岳县人民医院临床药学科,四川 资阳 642350)])]), Author(id=1325223681844196104, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325223681949053706, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, authorId=1325223681844196104, language=EN, stringName=Debing ZHOU, firstName=Debing, middleName=null, lastName=ZHOU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=b, *, address=b.Department of Clinical Pharmacy, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325223682041328395, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, authorId=1325223681844196104, language=CN, stringName=周德兵, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=b, *, address=b.安岳县人民医院临床药学科,四川 资阳 642350, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325223679105315577, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, xref=b., ext=[AuthorCompanyExt(id=1325223679126287098, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223679105315577, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.Department of Clinical Pharmacy, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China), AuthorCompanyExt(id=1325223679134675707, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325223678186762995, companyId=1325223679105315577, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=b.安岳县人民医院临床药学科,四川 资阳 642350)])])]
沈小钦a, 李永伟b, 周德兵b, *
作者信息
  • a.安岳县人民医院呼吸与危重症科,四川 资阳 642350
  • b.安岳县人民医院临床药学科,四川 资阳 642350
通讯作者:
周德兵,副主任药师,研究方向:抗感染领域。
作者简介:

沈小钦,副主任医师,研究方向:慢性气道疾病与肺部感染性疾病。

Exploration of the therapeutic mechanism of mepolizumab in patients with type 2 inflammatory bronchial asthma
Xiaoqin SHENa, Yongwei LIb, Debing ZHOUb, *
Affiliations
  • a.Department of Respiratory and Critical Care Medicine, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China
  • b.Department of Clinical Pharmacy, Anyue County People's Hospital, Ziyang 642350, Sichuan Province, China
出版时间: 2026-05-10 doi: 10.13683/j.wph.2026.05.007
文章导航
收藏切换
目的

评价美泊利珠单抗对2型炎症支气管哮喘的治疗机制。

方法

回顾性收集我院2024年3月至2025年1月接受治疗的102例2型支气管哮喘患者的临床资料,依照不同治疗方案分组。对照组治疗方案包括布地奈德福莫特罗、口服糖皮质激素(oral glucocorticosteroid,OCS)泼尼松;观察组在对照组治疗基础上联用美泊利珠单抗。收集并比较两组治疗6个月的情况,包括哮喘控制测试(asthma control test,ACT)评分、OCS用量、嗜酸性粒细胞(eosinophil,EOS)计数、免疫球蛋白(immunoglobulin,Ig)E、呼出气一氧化氮(fractional exhaled nitric oxide,FeNO)、用力肺活量(forced vital capacity,FVC)、第1秒用力呼气容积(forced expiratory volume in one second,FEV1)、呼气峰值流量(peak expiratory flow,PEF)、支气管总面积(total bronchial surface area,TA)、管腔面积(lumen area,LA)、管壁面积(wall area of tube,WA)等指标结果,并比较随访12个月的因哮喘加重再入院的次数。

结果

治疗后,观察组ACT评分、OCS用量较对照组的降低更明显(P<0.05),EOS计数、IgE、FeNO水平较对照组更低(P<0.05),且观察组FVC、FEV1/FVC、PEF较对照组更高(P<0.05)。观察组LA高于对照组(P<0.05),WA低于对照组(P<0.05)。随访12个月,结果显示,观察组因哮喘加重的再入院次数少于对照组(P<0.05);经多因素逻辑回归分析显示,基线EOS、FeNO是基于ACT评分评价治疗应答的独立预测因素(P<0.05)。

结论

美泊利珠单抗有助控制2型炎症支气管哮喘病情,帮助减少OCS用量,推测主要作用机制与靶向阻断2型炎症生物标志物、改善气道重构有关。

2型炎症支气管哮喘  /  美泊利珠单抗  /  糖皮质激素  /  肺功能  /  气道重塑
Objective

To evaluate the therapeutic mechanism of mepolizumab in type 2 inflammatory bronchial asthma.

Methods

The clinical data of 102 patients with type 2 bronchial asthma who were treated in our hospital from March 2024 to January 2025 were collected retrospectively. They were grouped according to different treatment regimens. The control group treated with budesonide formoterol and oral glucocorticosteroid(OCS) prednisone, while the observation group received mepolizumab in addition to the control group. The conditions of both groups after 6 months of treatment were collected and compared, including asthma control test(ACT) score, OCS dosage, eosinophil(EOS) count,immunoglobulin(Ig)E, fractional exhaled nitric oxide(FeNO), forced vital capacity(FVC), forced expiratory volume in one second(FEV1), peak expiratory flow(PEF), total bronchial surface area(TA), lumen area(LA), and wall area of tube(WA), and the number of readmissions due to asthma exacerbation over a 12-month follow-up period.

Results

After treatment, the ACT score and OCS dosage in the observation group decreased more significantly compared with the control group(P<0.05), while the EOS count, IgE, and FeNO were lower in the observation group than in the control group(P<0.05), and the FVC, FEV1/FVC, and PEF in the observation group were higher than those in the control group(P<0.05).The LA in the observation group was higher than that in the control group(P<0.05), and the WA was lower than that in the control group(P<0.05), the 12-month follow-up showed that the number of re-admissions due to asthma exacerbation in the observation group was less than those in the control group(P<0.05). The multivariate logistic regression analysis showed that baseline EOS and FeNO were independent predictors for evaluating treatment response based on the ACT scoring(P<0.05).

Conclusion

Mepolizumab helps control the condition of type 2 inflammatory bronchial asthma, reduces the dosage of OCS. The main mechanism of action is speculated to be targeting the blockade of type 2 inflammatory biomarkers and improving airway remodeling.

type 2 inflammatory bronchial asthma  /  mepolizumab  /  glucocorticosteroid  /  pulmonary function  /  airway remodeling
沈小钦, 李永伟, 周德兵. 美泊利珠单抗对2型炎症支气管哮喘患者的治疗机制探索. 世界临床药物, 2026 , 47 (5) : 502 -507 . DOI: 10.13683/j.wph.2026.05.007
Xiaoqin SHEN, Yongwei LI, Debing ZHOU. Exploration of the therapeutic mechanism of mepolizumab in patients with type 2 inflammatory bronchial asthma[J]. World Clinical Drug, 2026 , 47 (5) : 502 -507 . DOI: 10.13683/j.wph.2026.05.007

参考文献 引证文献
排序方式:
[1]
MATUCCI A, MICHELETTO C, VULTAGGIO A. Severe asthma and biologics: managing complex patients[J]. J Investig Allergol Clin Immunol, 2023, 33(3): 168-178.
[2]
DENG Z, JIN M, OU C, et al. Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies[J]. Chin Med J(Engl), 2023, 136(2): 230-232.
[3]
中华医学会呼吸病学分会. 支气管哮喘防治指南(2024 年版)[J]. 中华结核和呼吸杂志, 2025, 48(3): 208-248.
[4]
THOMAS D, MCDONALD VM, STEVENS S, et al.Biologics(mepolizumab and omalizumab) induced remission in severe asthma patients[J]. Allergy, 2024, 79(2): 384-392.
[5]
王雯, 郭越, 李洁莹, 等. 度普利尤单抗治疗中重度哮喘的疗效及安全性分析: 一项真实世界研究[J]. 中国呼吸与危重监护杂志, 2023, 22(10): 685-691.
[6]
乌日娜, 杨敬平, 徐喜媛. 肺功能及哮喘控制测试(ACT)在哮喘患者管理中的价值[J]. 临床肺科杂志, 2012, 17(7):1232-1233.
[7]
张明强, 牟向东. 2 型炎症型支气管哮喘的生物靶向治疗[J]. 新医学, 2024, 55(11): 944-949.
[8]
LOMMATZSCH M, BRUSSELLE GG, LEVY ML, et al. A2BCD:a concise guide for asthma management[J]. Lancet Respir Med, 2023, 11(6): 573-576.
[9]
AKENROYE AT, SEGAL JB, ZHOU G, et al. Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: a target trial emulation[J]. J Allergy Clin Immunol,2023, 151(5): 1269-1276.
[10]
NOPSOPON T, LASSITER G, CHEN ML, et al. Comparative efficacy of tezepelumab to mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: a Bayesian network meta-analysis[J]. J Allergy Clin Immunol, 2023, 151(3): 747-755.
[11]
LIU MC, BAGNASCO D, MATUCCI A, et al. Mepolizumab in patients with severe asthma and comorbidities: 1-year REALITI-A analysis[J]. J Allergy Clin Immunol Pract, 2023,11(12): 3650-3661.
[12]
DIGHRIRI IM, ALNUGHAYTHIR AI, ALBESISI AA, et al.Efficacy and safety of mepolizumab in the management of severe eosinophilic asthma: a systematic review[J]. Cureus,2023, 15(12): e49781.
[13]
李亚, 杨卫, 张红, 等. 血清炎症因子与支气管哮喘气道重构相关性的研究进展[J]. 医学综述, 2023, 29(8): 1492-1496.
[14]
SAVIN IA, ZENKOVA MA, SEN KOVA AV. Bronchial asthma, airway remodeling and lung fibrosis as successive steps of one process[J]. Int J Mol Sci, 2023, 24(22): 16042.
[15]
徐震, 张海生, 赵杰, 等. 美泊利单抗治疗严重哮喘患者的临床研究[J]. 中国临床药理学杂志, 2025, 41(13): 1811-1815.
[16]
STRAUSS R, LEFLEIN H, KOLESAR A, et al. Long-term efficacy and safety among patients with severe eosinophilic asthma treated with mepolizumab and its effect on small airways[J]. J Allergy Clin Immunol Pract, 2023, 11(12):3670-3679.
2026年第47卷第5期
55
12
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2026.05.007
  • 接收时间:2025-08-25
  • 首发时间:2026-11-05
  • 出版时间:2026-05-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-08-25
  • 修回日期:2026-04-12
基金
作者信息
    a.安岳县人民医院呼吸与危重症科,四川 资阳 642350
    b.安岳县人民医院临床药学科,四川 资阳 642350

通讯作者:

周德兵,副主任药师,研究方向:抗感染领域。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.05.007
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏